Sign Up Today and Learn More About test Stock
Invest in or calculate the value of your shares in test or other pre-IPO companies through EquityZen's platform.
About test Stock
Founded
2005
Total Funding
151M
Industries
Software, Artificial Intelligence, Data and Analytics
Kareo is a profitable and rapidly growing company that delivers cloud-based software that helps over 30,000 small practice physicians run their business and get paid by insurance companies and patients. Kareo does this by helping small practice physicians shift from complex and expensive legacy software to intuitive and affordable cloud-based solutions. Kareo also helps small practice physicians by eliminating licensing fees, which allows doctors to run their businesses without the legal handcuffs of multi-year contracts.
test Press Mentions
Stay in the know about the latest news on test
Kareo Secures over $55 Million in Investment to Extend Market Leadership
Kareo • Jul 28, 2015
Fast-Growing Kareo Lands $29M To Help Doctors Move Their Practices Into The Cloud
TechCrunch • Jan 21, 2014
Kareo Raises $20.5M Series F for New Cloud-Based Medical-Billing Software
Kareo • Jan 22, 2013
Kareo Raises $20.5 Million to Fuel Rapid Growth
Kareo • Jan 22, 2013
Investors in test
Discover investors in test stock and explore their portfolio companies
test Management
Leadership team at test
Founder and CEO
Dan Rodrigues
Chief Medical Information Officer
Tom Giannulli
Join now and verify your accreditation status to gain access to:
- test current valuation
- test stock price
- Available deals in test and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in test stock?
Accredited investors can buy pre-IPO stock in companies like test through EquityZen funds. These investments are made available by existing test shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell test stock?
Shareholders can sell their test stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."